Last Updated : March 17, 2016
Details
FilesGeneric Name:
Brivaracetam
Project Status:
Complete
Therapeutic Area:
Epilepsy, partial-onset seizures
Manufacturer:
UCB Canada Inc.
Call for patient/clinician input open:
Brand Name:
Brivlera
Project Line:
Reimbursement Review
Project Number:
SR0484-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
Achieved
Submission Type:
Initial
Indications:
Epilepsy, partial-onset seizures
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : March 17, 2016